Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, Münster, D-48149, Germany.
Myocellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Münster, D-48149, Germany.
Eur J Med Chem. 2018 Oct 5;158:259-269. doi: 10.1016/j.ejmech.2018.09.006. Epub 2018 Sep 6.
GluN2A containing N-methyl-D-aspartate receptors (NMDARs) are important ion channels in the central nervous system and highly involved in several different neurophysiological but also neuropathophysiological processes. However, current understanding of the contribution of GluN2A containing NMDARs in these processes is incomplete. Therefore, highly selective compounds are required to further investigate these ion channels. In 2010, TCN-201 (2), one of the first selective negative allosteric modulators was reported. While the binding site of 2 and the influence of the substitution pattern of the benzenesulfonamide part has been reported recently, detailed structure-activity-relationships of the diacylhydrazine part and the linked phenyl moiety are still missing. In order to examine the critical interactions between these moieties and the binding site, several TCN-201 analogs with modified diacylhydrazine part were synthesized. The negative allosteric effect was recorded by two-electrode voltage clamp (TEVC) experiments using GluN1a/GluN2A expressing Xenopus laevis oocytes. Our data led to the conclusion, that the terminal phenyl moiety is involved in a cation-π-interaction with the guanidinium moiety of Arg755 of the GluN1a subunit, which plays a crucial role for high activity. Additionally, structure optimization by replacing the phenyl moiety with a thiophen-2-yl (10c), indol-2-yl (10g) or indol-3-yl (10h) moiety significantly increased the activity of 2 by the factor 2.5. At a test compound concentration of 200 nM, the negative allosteric effect of the most potent ligands 10c, 10h and 17 was significantly influenced by the glycine concentration. Although glycine dependency is higher than those of the lead compound 4, 10c and 17 showed significantly higher negative allosteric effects than 4 at glycine concentrations from 1 μM up to 10 μM. The potent GluN2A-NMDA receptor inhibitors 10c, 10h and 17 did not influence the ion current of GluN2B-NMDA receptors.
含有 GluN2A 的 N-甲基-D-天冬氨酸受体 (NMDARs) 是中枢神经系统中重要的离子通道,广泛参与多种不同的神经生理和神经病理生理过程。然而,目前对于这些过程中 GluN2A 含有的 NMDAR 的贡献的理解并不完整。因此,需要高度选择性的化合物来进一步研究这些离子通道。2010 年,报道了第一个选择性负变构调节剂 TCN-201(2)。虽然最近报道了 2 的结合位点和苯磺酰胺部分取代模式的影响,但二酰肼部分和连接的苯基部分的详细构效关系仍然缺失。为了研究这些部分与结合位点之间的关键相互作用,合成了几种具有修饰的二酰肼部分的 TCN-201 类似物。通过使用表达 GluN1a/GluN2A 的非洲爪蟾卵母细胞的双电极电压钳 (TEVC) 实验记录负变构效应。我们的数据得出结论,末端苯基部分与 GluN1a 亚基的胍基部分的阳离子-π 相互作用,这对于高活性至关重要。此外,通过用噻吩-2-基 (10c)、吲哚-2-基 (10g) 或吲哚-3-基 (10h) 部分取代苯基部分进行结构优化,显著提高了 2 的活性 2.5 倍。在测试化合物浓度为 200 nM 时,最有效配体 10c、10h 和 17 的负变构效应受甘氨酸浓度的显著影响。尽管甘氨酸依赖性高于先导化合物 4,但在甘氨酸浓度从 1 μM 到 10 μM 范围内,10c 和 17 的负变构效应明显高于 4。有效的 GluN2A-NMDA 受体抑制剂 10c、10h 和 17 不影响 GluN2B-NMDA 受体的离子电流。